Skip to main content
Premium Trial:

Request an Annual Quote

Cleveland Hospital Selects GenomOncology's Software to Support NGS-based Cancer Test

Premium

NEW YORK (GenomeWeb) –GenomOncology said this week that University Hospitals' Case Medical Center and Seidman Cancer Center will use its GO Clinical Workbench software to launch their first next-generation sequencing-based cancer diagnostic test.

The UH centers will use GenomOncology's GO to manage the workflows they use to analyze raw sequence data all the way through to delivering actionable clinical reports, the company said. The system offers tools for things like checking the quality of sequencing runs and samples, and for annotating and reporting on tumor variants that will "allow us to quickly translate scientific findings into the higher quality patient care," Joseph Willis, division chief of clinical pathology at UH Case Medical Center, said in a statement. Customers can tailor the GO platform to their lab's specific needs and integrate it with existing infrastructure such as laboratory information management systems and so on.

Financial and other terms of the agreement were not disclosed.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.